−0.4316USD
−8.533MUSD
25.841M
About MYDECINE INNOVATIONS GROUP INC NEW
Sector
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
Employees (FY)
3
Founded
2013
ISIN
CA62849F2008
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
MYCO finally movingMyco finally broke out of the downward trend. I am expecting it to restest the 200ma on the daily chart.
My targets:
.32
.395
.435
Bullish PennantI can see this hitting as high as 0.69 cents a share should we break through to the upside. RSI over 50.
Mydecine Innovations Group Bull RunLT’s Comments : Let’s take a look at Mydecine Innovations Group logically and not just go crazy on what is being published out there for investors. We will go through its performance and its capability of real market price. How far can this company go?
SEC Financial Filing
Sept 30,2020
Current: $
MYCO - Next Move? MYCO has formed a prefect cup & handle on the daily
- 4 hits against an important 0.60 resistance
- handle dropped perfectly on the 0.5 fib support level
- price is currently consolidating right below resistance
Fundamentals in the psychedelic space are lining up perfectly for a MYCO breakout.
- t
MYCO she will be ready to pop very soonThe way I see it ....is myco should be making another run in the next couple of days heading towards the $1.10 mark, my guess is it will make it there within 2 weeks. What do you see?
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
